Meclizine HCl
- Product NDC
- 57237-333
- 11-digit product format
- 572370333
- Labeler code
- 57237
- Product ID
- 57237-333_f603203c-84a4-4b41-a244-cff913e5c2e0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- MECLIZINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- M009.50
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-07-22
- Substance
- MECLIZINE HYDROCHLORIDE
- Active strength
- 12.5 mg/1
- Pharmacologic classes
- Antiemetic [EPC], Emesis Suppression [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meclizine HCl
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MECLIZINE HYDROCHLORIDE | 12.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | HDP7W44CIO |
| Rxcui | 995624 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 57237-333-01 | Meclizine HCl | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 57237-333 | MECLIZINE HCL (MECLIZINE HYDROCHLORIDE) TABLET [RISING PHARMA HOLDINGS, INC.] | 3 | Current NDC, 1 package rows | 20241116_acdf636c-66f1-4a1f-87a8-786f51d75708.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 57237-333-01 | 57237033301 | 100 TABLET in 1 BOTTLE (57237-333-01) | 100 tablet | 2024-07-22 | No | No | Current |